1 growth of lymphocytes latently infected with
Kaposi's sarcoma-associated herpesvirus.
2 dies on the human gammaherpesviruses EBV and
Kaposi's sarcoma-associated herpesvirus.
3 is a non-Hodgkin's B-cell lymphoma driven by
Kaposi's sarcoma-associated herpesvirus.
4 atency-associated nuclear antigen (LANA) for
Kaposi's sarcoma-associated herpesvirus.
5 rcoma (KS) is a multicentric tumor caused by
Kaposi's sarcoma-associated herpesvirus.
6 ted with one of oncogenic viruses infection,
Kaposi's sarcoma-associated herpesvirus.
7 the organization of this protein complex for
Kaposi's sarcoma-associated herpesvirus.
8 Similarly,
Kaposi's sarcoma-associated herpesvirus also did not sti
9 Unique to gamma-herpesviruses, like
Kaposi's sarcoma-associated herpesvirus and Epstein-Barr
10 Two other oncogenic herpesviruses,
Kaposi's sarcoma-associated herpesvirus and Marek's dise
11 Kaposi's sarcoma-associated herpesvirus and rhesus macaq
12 ich tumor cells are consistently infected by
Kaposi's sarcoma-associated herpesvirus and usually grow
13 d from a newly established and characterized
Kaposi's sarcoma-associated herpesvirus-
and Epstein-Bar
14 view the evidence for Epstein-Barr virus and
Kaposi's sarcoma-associated herpesvirus as causal lympho
15 ciated polyomavirus, Epstein-Barr virus, and
Kaposi's sarcoma-associated herpesvirus,
because GEMs ha
16 Self-assembly of
Kaposi's sarcoma-associated herpesvirus capsids occurs w
17 c mechanisms by which Epstein-Barr virus and
Kaposi's sarcoma-associated herpesvirus cause B-cell lym
18 ORFK3 (K3) and ORFK5 (K5) are
Kaposi's sarcoma-associated herpesvirus-
encoded E3 ubiqu
19 Kaposi's sarcoma-associated herpesvirus-
encoded vFLIP K1
20 Kaposi's sarcoma-associated herpesvirus-
encoded viral FL
21 tors (e.g., herpes simplex virus nectin1 and
Kaposi's sarcoma-associated herpesvirus EphA2), or assoc
22 The human gamma-herpesviruses EBV and
Kaposi's sarcoma-associated herpesvirus establish lifelo
23 ovirus (HCMV), Epstein-Barr virus (EBV), and
Kaposi's sarcoma-associated herpesvirus,
establish laten
24 IL-4 also reactivated human
Kaposi's sarcoma-associated herpesvirus from latency in
25 a 50 years ago, only one other virus, namely
Kaposi's sarcoma-associated herpesvirus/
human herpesviru
26 omolog, the oncogenic human gammaherpesvirus
Kaposi's sarcoma-associated herpesvirus/
human herpesviru
27 Microbe, Chang and Ganem (2013) report that
Kaposi's sarcoma-associated herpesvirus infection of lym
28 endothelial cells (ECs), a natural target of
Kaposi's sarcoma-associated herpesvirus infection.
29 Kaposi's sarcoma-associated herpesvirus is a leading cau
30 coding-polyadenylated nuclear (PAN) RNA from
Kaposi's sarcoma-associated herpesvirus is conferred by
31 Kaposi's sarcoma-associated herpesvirus is the causative
32 Kaposi's sarcoma associated herpesvirus (
KSHV) establish
33 Human herpes virus 8 (HHV-8), also known as
Kaposi's sarcoma associated herpesvirus (
KSHV), is an on
34 Kaposi's sarcoma-associated herpesvirus (
KSHV [human her
35 r maturation of RRV, the closest relative of
Kaposi's sarcoma-associated herpesvirus (
KSHV) (a human
36 Kaposi's sarcoma-associated herpesvirus (
KSHV) and Epste
37 protein (SCP) of human tumor herpesviruses--
Kaposi's sarcoma-associated herpesvirus (
KSHV) and Epste
38 ame 50 (ORF50) DNA template in the genome of
Kaposi's sarcoma-associated herpesvirus (
KSHV) and has b
39 Two closely related gammaherpesviruses,
Kaposi's sarcoma-associated herpesvirus (
KSHV) and rhesu
40 Kaposi's sarcoma-associated herpesvirus (
KSHV) and the c
41 Kaposi's sarcoma-associated herpesvirus (
KSHV) and the c
42 igen (LANA) is central to the maintenance of
Kaposi's sarcoma-associated herpesvirus (
KSHV) and to th
43 lytic cycles of Epstein-Barr virus (EBV) and
Kaposi's sarcoma-associated herpesvirus (
KSHV) are induc
44 DNA tumor viruses such as
Kaposi's sarcoma-associated herpesvirus (
KSHV) are known
45 Using the dimeric protease (Pr) from
Kaposi's sarcoma-associated herpesvirus (
KSHV) as a mode
46 latency-associated nuclear antigen (LANA) of
Kaposi's sarcoma-associated herpesvirus (
KSHV) binds p53
47 maherpesviruses Epstein-Barr virus (EBV) and
Kaposi's sarcoma-associated herpesvirus (
KSHV) cause lif
48 ive stages of the KSHV life cycle.IMPORTANCE
Kaposi's sarcoma-associated herpesvirus (
KSHV) causes AI
49 Kaposi's sarcoma-associated herpesvirus (
KSHV) causes Ka
50 Kaposi's sarcoma-associated herpesvirus (
KSHV) causes tw
51 Kaposi's sarcoma-associated herpesvirus (
KSHV) displays
52 ent SCFAs stimulate lytic gene expression of
Kaposi's sarcoma-associated herpesvirus (
KSHV) dose depe
53 Human
Kaposi's sarcoma-associated herpesvirus (
KSHV) effective
54 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes 1
55 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes 1
56 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes 1
57 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes a
58 The open reading frame K8 of
Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes a
59 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes m
60 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes n
61 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes O
62 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes s
63 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes t
64 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes t
65 Kaposi's sarcoma-associated herpesvirus (
KSHV) encodes t
66 encoded by open reading frame 36 (ORF36) of
Kaposi's sarcoma-associated herpesvirus (
KSHV) enhances
67 Kaposi's sarcoma-associated herpesvirus (
KSHV) enters hu
68 Latent
Kaposi's sarcoma-associated herpesvirus (
KSHV) episomes
69 Kaposi's sarcoma-associated herpesvirus (
KSHV) establish
70 Kaposi's sarcoma-associated herpesvirus (
KSHV) establish
71 Kaposi's sarcoma-associated herpesvirus (
KSHV) establish
72 Kaposi's sarcoma-associated herpesvirus (
KSHV) evades ho
73 We have previously discovered that
Kaposi's sarcoma-associated herpesvirus (
KSHV) evades th
74 Kaposi's sarcoma-associated herpesvirus (
KSHV) expresses
75 During lytic infection,
Kaposi's sarcoma-associated herpesvirus (
KSHV) expresses
76 The oncogenic human gammaherpesvirus
Kaposi's sarcoma-associated herpesvirus (
KSHV) expresses
77 Kaposi's sarcoma-associated herpesvirus (
KSHV) expresses
78 The human oncogenic
Kaposi's sarcoma-associated herpesvirus (
KSHV) expresses
79 inity tagged and purified all 89 proteins of
Kaposi's sarcoma-associated herpesvirus (
KSHV) from huma
80 Lytic activation of
Kaposi's sarcoma-associated herpesvirus (
KSHV) from late
81 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) G protein
82 Kaposi's sarcoma-associated herpesvirus (
KSHV) G protein
83 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) G protein
84 During latent infection, the majority of
Kaposi's sarcoma-associated herpesvirus (
KSHV) genes is
85 ous transcription across the entirety of the
Kaposi's sarcoma-associated herpesvirus (
KSHV) genome an
86 LANA is essential for tethering the
Kaposi's sarcoma-associated herpesvirus (
KSHV) genome to
87 e found that most transcripts encoded by the
Kaposi's sarcoma-associated herpesvirus (
KSHV) genome un
88 Latent
Kaposi's sarcoma-associated herpesvirus (
KSHV) genomes e
89 y focal assembly of RNA polymerase II around
Kaposi's sarcoma-associated herpesvirus (
KSHV) genomes i
90 The maintenance of latent
Kaposi's sarcoma-associated herpesvirus (
KSHV) genomes i
91 ected cells.IMPORTANCE B cells infected with
Kaposi's sarcoma-associated herpesvirus (
KSHV) harbor mu
92 Kaposi's sarcoma-associated herpesvirus (
KSHV) has a cau
93 virus (EBV) is a ubiquitous herpesvirus, and
Kaposi's sarcoma-associated herpesvirus (
KSHV) has a res
94 Kaposi's sarcoma-associated herpesvirus (
KSHV) has a sig
95 Kaposi's sarcoma-associated herpesvirus (
KSHV) has been
96 Kaposi's sarcoma-associated herpesvirus (
KSHV) has been
97 the transcription of individual genes of the
Kaposi's sarcoma-associated herpesvirus (
KSHV) has been
98 enetic modification of herpesviruses such as
Kaposi's sarcoma-associated herpesvirus (
KSHV) has come
99 Oncogenic
Kaposi's sarcoma-associated herpesvirus (
KSHV) has laten
100 Kaposi's sarcoma-associated herpesvirus (
KSHV) has tropi
101 Here, we report that the
Kaposi's sarcoma-associated herpesvirus (
KSHV) immediate
102 l microvascular endothelial cells (HMVEC-d),
Kaposi's sarcoma-associated herpesvirus (
KSHV) induced t
103 we present an innovative approach to culture
Kaposi's sarcoma-associated herpesvirus (
KSHV) infected
104 d levels of viral lytic gene expression when
Kaposi's sarcoma-associated herpesvirus (
KSHV) infected
105 was undertaken to determine whether de novo
Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
106 an effective small-animal model to study the
Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
107 L) is a lymphogenic disorder associated with
Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
108 Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
109 Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
110 lar RNA degradation enzyme Xrn1 during lytic
Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
111 mined the expression of the DDR genes during
Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
112 The development of a mouse model for
Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
113 Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
114 Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
115 oma is an angioproliferative tumor caused by
Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
116 Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
117 Kaposi's sarcoma-associated herpesvirus (
KSHV) infection
118 Kaposi's sarcoma-associated herpesvirus (
KSHV) infects m
119 Latent DNA replication of
Kaposi's sarcoma-associated herpesvirus (
KSHV) initiates
120 Kaposi's sarcoma-associated herpesvirus (
KSHV) interacts
121 The K15P membrane protein of
Kaposi's sarcoma-associated herpesvirus (
KSHV) interacts
122 Kaposi's sarcoma-associated herpesvirus (
KSHV) interacts
123 The entry of
Kaposi's sarcoma-associated herpesvirus (
KSHV) into huma
124 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a B-ly
125 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) is a comm
126 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a DNA
127 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a gamm
128 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a gamm
129 The ORF45 protein of
Kaposi's sarcoma-associated herpesvirus (
KSHV) is a gamm
130 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a huma
131 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a huma
132 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a huma
133 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a huma
134 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a huma
135 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a huma
136 Kaposi's sarcoma-associated herpesvirus (
KSHV) is a prom
137 itch between the latency and lytic cycles of
Kaposi's sarcoma-associated herpesvirus (
KSHV) is accomp
138 Open reading frame 45 (ORF45) of
Kaposi's sarcoma-associated herpesvirus (
KSHV) is an imm
139 Kaposi's sarcoma-associated herpesvirus (
KSHV) is an onc
140 Kaposi's sarcoma-associated herpesvirus (
KSHV) is associ
141 Kaposi's Sarcoma-associated Herpesvirus (
KSHV) is associ
142 Kaposi's sarcoma-associated herpesvirus (
KSHV) is associ
143 Kaposi's sarcoma-associated herpesvirus (
KSHV) is causal
144 Kaposi's sarcoma-associated herpesvirus (
KSHV) is causat
145 associated nuclear antigen (LANA) encoded by
Kaposi's sarcoma-associated herpesvirus (
KSHV) is critic
146 The K1 gene product of
Kaposi's sarcoma-associated herpesvirus (
KSHV) is encode
147 Kaposi's sarcoma-associated herpesvirus (
KSHV) is etiolo
148 Kaposi's sarcoma-associated herpesvirus (
KSHV) is etiolo
149 Kaposi's sarcoma-associated herpesvirus (
KSHV) is etiolo
150 Kaposi's sarcoma-associated herpesvirus (
KSHV) is etiolo
151 Kaposi's sarcoma-associated herpesvirus (
KSHV) is linked
152 Kaposi's sarcoma-associated herpesvirus (
KSHV) is linked
153 Kaposi's sarcoma-associated herpesvirus (
KSHV) is linked
154 Kaposi's sarcoma-associated herpesvirus (
KSHV) is linked
155 Kaposi's Sarcoma-associated herpesvirus (
KSHV) is mainta
156 Latent infection by
Kaposi's sarcoma-associated herpesvirus (
KSHV) is requir
157 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
158 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
159 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
160 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
161 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
162 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
163 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
164 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
165 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
166 Co-infection with HIV-1 and
Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
167 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
168 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
169 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the ca
170 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
171 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
172 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
173 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
174 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
175 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
176 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
177 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
178 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the et
179 Kaposi's sarcoma-associated herpesvirus (
KSHV) is the in
180 lytic phases.IMPORTANCE The K15P protein of
Kaposi's sarcoma-associated herpesvirus (
KSHV) is though
181 Lytic activation of the cancer-causing
Kaposi's sarcoma-associated herpesvirus (
KSHV) is vital
182 Kaposi's sarcoma-associated herpesvirus (
KSHV) K13/vFLIP
183 Kaposi's sarcoma-associated herpesvirus (
KSHV) LANA is a
184 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) LANA prot
185 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) LANA prot
186 Kaposi's sarcoma-associated herpesvirus (
KSHV) latency a
187 COX-2 has been implicated in
Kaposi's sarcoma-associated herpesvirus (
KSHV) latency a
188 We show that the
Kaposi's sarcoma-associated herpesvirus (
KSHV) latency l
189 Kaposi's sarcoma-associated herpesvirus (
KSHV) latency-a
190 HV68) ORF73 (mLANA) has sequence homology to
Kaposi's sarcoma-associated herpesvirus (
KSHV) latency-a
191 Kaposi's sarcoma-associated herpesvirus (
KSHV) latency-a
192 Specific regions of
Kaposi's sarcoma-associated herpesvirus (
KSHV) latent ep
193 Kaposi's sarcoma-associated herpesvirus (
KSHV) latent ge
194 Myc is deregulated by
Kaposi's sarcoma-associated herpesvirus (
KSHV) latent pr
195 factors (HIFs) play an important role in the
Kaposi's sarcoma-associated herpesvirus (
KSHV) life cycl
196 Kaposi's sarcoma-associated herpesvirus (
KSHV) lytic inf
197 at the constitutive AMPK activity restricted
Kaposi's sarcoma-associated herpesvirus (
KSHV) lytic rep
198 Kaposi's sarcoma-associated herpesvirus (
KSHV) maintains
199 Sequence comparisons to human
Kaposi's sarcoma-associated herpesvirus (
KSHV) miRNAs re
200 DSBs) in DNA, although detail concerning how
Kaposi's sarcoma-associated herpesvirus (
KSHV) modulates
201 egy of selectively isolating VLVs by using a
Kaposi's sarcoma-associated herpesvirus (
KSHV) mutant th
202 Previously, we showed that the
Kaposi's sarcoma-associated herpesvirus (
KSHV) NEC speci
203 Spontaneous lytic reactivation of
Kaposi's sarcoma-associated herpesvirus (
KSHV) occurs at
204 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) open read
205 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) open read
206 ere, we identify a viral trimeric complex of
Kaposi's sarcoma-associated herpesvirus (
KSHV) open read
207 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF36 pro
208 Although
Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF52 (al
209 We report here that
Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF52, an
210 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF57 gen
211 Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF57 pla
212 report that PABPC1 forms a complex with the
Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF57 pro
213 The
Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF57 pro
214 Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF57 pro
215 Kaposi's sarcoma-associated herpesvirus (
KSHV) ORF6 is h
216 ncy-associated nuclear antigen (LANA) of the
Kaposi's sarcoma-associated herpesvirus (
KSHV) performs
217 Here, we show that increased levels of
Kaposi's sarcoma-associated herpesvirus (
KSHV) persisten
218 associated nuclear antigen (LANA) encoded by
Kaposi's sarcoma-associated herpesvirus (
KSHV) plays a m
219 ORF59 of
Kaposi's sarcoma-associated herpesvirus (
KSHV) plays an
220 Kaposi's sarcoma-associated herpesvirus (
KSHV) remains p
221 nprecedented mechanism of viral replication:
Kaposi's sarcoma-associated herpesvirus (
KSHV) stably cl
222 recently showed that the interaction between
Kaposi's sarcoma-associated herpesvirus (
KSHV) tegument
223 ed to murine gammaherpesvirus 68 (MHV68) and
Kaposi's sarcoma-associated herpesvirus (
KSHV) that esta
224 e kinase A2 (EphA2) is an entry receptor for
Kaposi's sarcoma-associated herpesvirus (
KSHV) that is e
225 sociated substrate) as a platform to promote
Kaposi's sarcoma-associated herpesvirus (
KSHV) trafficki
226 Here we map the 3' UTRs of
Kaposi's sarcoma-associated herpesvirus (
KSHV) using nex
227 Kaposi's sarcoma-associated herpesvirus (
KSHV) utilizes
228 o-electron microscopy (cryo-EM) structure of
Kaposi's sarcoma-associated herpesvirus (
KSHV) virion, a
229 rophoretic response of B cells infected with
Kaposi's sarcoma-associated herpesvirus (
KSHV) were inve
230 e expression occurs upon superinfection with
Kaposi's sarcoma-associated herpesvirus (
KSHV), a common
231 Kaposi's sarcoma-associated herpesvirus (
KSHV), a DNA tu
232 We report that ORF10 of
Kaposi's sarcoma-associated herpesvirus (
KSHV), a nuclea
233 iral FLICE-like inhibitor protein (vFLIP) of
Kaposi's sarcoma-associated herpesvirus (
KSHV), against
234 Kaposi's sarcoma-associated herpesvirus (
KSHV), also kno
235 ncy is an integral part of the life cycle of
Kaposi's sarcoma-associated herpesvirus (
KSHV), an etiol
236 RV) is a gammaherpesvirus closely related to
Kaposi's sarcoma-associated herpesvirus (
KSHV), an oncog
237 V1) lineage consists of human herpesvirus 8,
Kaposi's sarcoma-associated herpesvirus (
KSHV), and clos
238 osely related to human herpesvirus 8 (HHV-8)/
Kaposi's Sarcoma-associated herpesvirus (
KSHV), and it i
239 the replication of the oncogenic herpesvirus
Kaposi's sarcoma-associated herpesvirus (
KSHV), by targe
240 , an immediate-early and tegument protein of
Kaposi's sarcoma-associated herpesvirus (
KSHV), causes s
241 novirus (RRV), a close relative of the human
Kaposi's sarcoma-associated herpesvirus (
KSHV), could be
242 Kaposi's sarcoma-associated herpesvirus (
KSHV), etiologi
243 n adaptive immunity, many viruses, including
Kaposi's sarcoma-associated herpesvirus (
KSHV), have evo
244 othelial cells during de novo infection with
Kaposi's sarcoma-associated herpesvirus (
KSHV), in cells
245 aherpesviruses, Epstein-Barr virus (EBV) and
Kaposi's sarcoma-associated herpesvirus (
KSHV), is assoc
246 (RRV), a close homolog of the human pathogen
Kaposi's sarcoma-associated herpesvirus (
KSHV), is compr
247 The human gammaherpesvirus,
Kaposi's sarcoma-associated herpesvirus (
KSHV), is tight
248 egument proteins of herpesviruses, including
Kaposi's sarcoma-associated herpesvirus (
KSHV), play key
249 cells are predominantly infected with latent
Kaposi's sarcoma-associated herpesvirus (
KSHV), presenti
250 50 promoters of Epstein-Barr virus (EBV) and
Kaposi's sarcoma-associated herpesvirus (
KSHV), respecti
251 Kaposi's sarcoma-associated herpesvirus (
KSHV), the caus
252 Kaposi's sarcoma-associated herpesvirus (
KSHV), the etio
253 Kaposi's sarcoma-associated herpesvirus (
KSHV), the etio
254 In the case of
Kaposi's sarcoma-associated herpesvirus (
KSHV), the etio
255 rld primates and are distinct but related to
Kaposi's sarcoma-associated herpesvirus (
KSHV), the etio
256 on lymphoma (PEL) cells infected with latent
Kaposi's sarcoma-associated herpesvirus (
KSHV), the prom
257 (RFHVMn), the pig-tailed macaque homolog of
Kaposi's sarcoma-associated herpesvirus (
KSHV), was dete
258 viral OX2 (vOX2) immunoregulator encoded by
Kaposi's sarcoma-associated herpesvirus (
KSHV), we have
259 maherpesviruses Epstein-Barr virus (EBV) and
Kaposi's sarcoma-associated herpesvirus (
KSHV), which ar
260 For oncogenic viruses such as
Kaposi's sarcoma-associated herpesvirus (
KSHV), which is
261 predominantly infected by the latent form of
Kaposi's sarcoma-associated herpesvirus (
KSHV), with vir
262 The four
Kaposi's sarcoma-associated herpesvirus (
KSHV)-encoded i
263 factor in the development and progression of
Kaposi's sarcoma-associated herpesvirus (
KSHV)-induced p
264 EBV infection and expressed in many EBV and
Kaposi's sarcoma-associated herpesvirus (
KSHV)-infected
265 Kaposi's sarcoma-associated herpesvirus (
KSHV)-related m
266 n by HIV-1 promotes the aggressive growth of
Kaposi's sarcoma-associated herpesvirus (
KSHV)-related m
267 vo infection of primary endothelial cells by
Kaposi's sarcoma-associated herpesvirus (
KSHV).
268 hundreds of genes during the reactivation of
Kaposi's sarcoma-associated herpesvirus (
KSHV).
269 form of aggressive B cell lymphoma caused by
Kaposi's sarcoma-associated herpesvirus (
KSHV).
270 e switch from latency to the lytic cycle for
Kaposi's sarcoma-associated herpesvirus (
KSHV).
271 ique subset that is linked to infection with
Kaposi's sarcoma-associated herpesvirus (
KSHV).
272 ive patients and universally associated with
Kaposi's sarcoma-associated herpesvirus (
KSHV).
273 C virus (HCV), Epstein-Barr virus (EBV), and
Kaposi's sarcoma-associated herpesvirus (
KSHV).
274 nown inflammation related diseases caused by
Kaposi's sarcoma-associated herpesvirus (
KSHV).
275 for lifelong persistence and pathogenesis of
Kaposi's sarcoma-associated herpesvirus (
KSHV).
276 erous proliferation of B cells, is caused by
Kaposi's sarcoma-associated herpesvirus (
KSHV).
277 Kaposi's sarcoma-associated herpesvirus (
KSHV)/human her
278 Kaposi's sarcoma-associated herpesvirus (
KSHV, also call
279 We recently showed that
Kaposi's sarcoma-associated herpesvirus (
KSHV, or human
280 For
Kaposi's sarcoma-associated herpesvirus (
KSHV; also call
281 Kaposi's sarcoma-associated herpesvirus (
KSHV; also know
282 Gammaherpesviruses, including
Kaposi's sarcoma-associated herpesvirus (
KSHV; also know
283 The responsible agent,
Kaposi's sarcoma-associated herpesvirus (
KSHV; HHV8), ex
284 Kaposi's sarcoma-associated herpesvirus (
KSHV; or human
285 16) recognizes nuclear episomal herpesvirus (
Kaposi's sarcoma-associated herpesvirus [
KSHV], Epstein-
286 ay to examine the lytic transcriptome of the
Kaposi's sarcoma-associated herpesvirus,
KSHV.
287 tigated the effect of autophagy on the KSHV (
Kaposi's sarcoma-associated herpesvirus)
life cycle.
288 The
Kaposi's sarcoma-associated herpesvirus nuclear egress c
289 ose relative of the human oncogenic pathogen
Kaposi's sarcoma-associated herpesvirus,
ORF52 is a high
290 he essential K5 transcript identified at the
Kaposi's sarcoma-associated herpesvirus OriLyt.
291 EL clinical samples, and three extracavitary
Kaposi's sarcoma-associated herpesvirus-
positive solid l
292 Kaposi's sarcoma-associated herpesvirus produces a highl
293 A small-molecule allosteric inhibitor of
Kaposi's sarcoma-associated herpesvirus protease (KSHV P
294 aHV68), a rodent pathogen related to EBV and
Kaposi's sarcoma-associated herpesvirus,
provides an imp
295 s, the cofactor activity (CFA), by using the
Kaposi's sarcoma-associated herpesvirus RCA homolog Kapo
296 genomes, those of human cytomegalovirus and
Kaposi's sarcoma-associated herpesvirus,
revealing trans
297 een shown to regulate Epstein-Barr virus and
Kaposi's sarcoma-associated herpesvirus Rta expression.
298 t HIV, together with a transient increase in
Kaposi's sarcoma-associated herpesvirus viral load at we
299 73 transcript and the MHV68 ORF63 homolog of
Kaposi's sarcoma-associated herpesvirus vNLRP1.
300 be infected with the human pathogens, EBV or
Kaposi's sarcoma-associated herpesvirus,
we have used a